2025
Motives for pornography use and women's sexual wellbeing: Insights from a 42-country study
Gewirtz-Meydan A, Feder H, Nagy L, Koós M, Kraus S, Demetrovics Z, Potenza M, Ballester-Arnal R, Batthyány D, Bergeron S, Billieux J, Briken P, Burkauskas J, Cárdenas-López G, Carvalho J, Castro-Calvo J, Chen L, Ciocca G, Corazza O, Csako R, Fernandez D, Fernandez E, Fujiwara H, Fuss J, Gabrhelík R, Gjoneska B, Gola M, Grubbs J, Hashim H, Islam S, Ismail M, Jiménez-Martínez M, Jurin T, Kalina O, Klein V, Költő A, Lee C, Lee S, Lewczuk K, Lin C, Lochner C, López-Alvarado S, Lukavská K, Mayta-Tristán P, Miller D, Orosová O, Orosz G, team S, Ponce F, Quintana G, Garzola G, Ramos-Diaz J, Rigaud K, Rousseau A, De Tubino Scanavino M, Schulmeyer M, Sharan P, Shibata M, Shoib, Sigre-Leirós V, Sniewski L, Spasovski O, Steibliene V, Stein D, Strizek J, Štulhofer A, Ünsal B, Vaillancourt-Morel M, Van Hout M, Bőthe B. Motives for pornography use and women's sexual wellbeing: Insights from a 42-country study. Journal Of Behavioral Addictions 2025, 14: 114-130. PMID: 39945771, PMCID: PMC11974412, DOI: 10.1556/2006.2024.00040.Peer-Reviewed Original ResearchConceptsPornography useSexual wellbeingWomen's motivationsSexual desireLack of sexual satisfactionSexual satisfactionSexual function problemsSelf-report survey designGrowing body of researchPornography use motivationsWomen's sexual wellbeingBody of researchPornographyHigher sexual desireSexual curiosityWellbeingMeasures of sexual functionMultifaceted natureParticipant ageWomenGrowing bodySurvey designLongitudinal designDesireParticipants
2022
Two-Year Analysis of a New Oral Testosterone Undecanoate (TU) Formulation in Hypogonadal Men: Efficacy, Impact on Psychosexual Function, and Safety.
Honig S, Gittelman M, Kaminetsky J, Wang C, Amory J, Rohowsky N, Dudley R, Woun Seo B, Newmark J, Swerdloff R. Two-Year Analysis of a New Oral Testosterone Undecanoate (TU) Formulation in Hypogonadal Men: Efficacy, Impact on Psychosexual Function, and Safety. The Journal Of Sexual Medicine 2022, 19: 1750-1758. PMID: 37057401, DOI: 10.1016/j.jsxm.2022.09.002.Peer-Reviewed Original ResearchConceptsTestosterone replacement therapyPsychosexual Daily QuestionnaireLiver function testsOral TUSerum T concentrationsSexual functionT concentrationsTU therapyHypogonadal menFunction testsEffective long-term treatment optionProstate-specific antigen levelHigh-density lipoprotein cholesterolLong-term treatment optionAdult hypogonadal menOral testosterone undecanoateTotal testosterone levelsSystolic blood pressureTotal T concentrationsActive-controlled trialYears of treatmentLong-term safetySignificant changesEugonadal rangeCardiovascular endpointsDiscontinuation of hormonal contraception due to changes in mood and decreases in sexual desire: the role of adverse childhood experiences
Novick AM, Johnson RL, Lazorwitz A, Belyavskaya A, Berkowitz L, Norton A, Sammel MD, Epperson CN. Discontinuation of hormonal contraception due to changes in mood and decreases in sexual desire: the role of adverse childhood experiences. The European Journal Of Contraception & Reproductive Health Care 2022, 27: 212-220. PMID: 35133231, PMCID: PMC9133050, DOI: 10.1080/13625187.2022.2030702.Peer-Reviewed Original Research
2016
Effects of Testosterone Treatment in Older Men
Snyder PJ, Bhasin S, Cunningham GR, Matsumoto AM, Stephens-Shields AJ, Cauley JA, Gill TM, Barrett-Connor E, Swerdloff RS, Wang C, Ensrud KE, Lewis CE, Farrar JT, Cella D, Rosen RC, Pahor M, Crandall JP, Molitch ME, Cifelli D, Dougar D, Fluharty L, Resnick SM, Storer TW, Anton S, Basaria S, Diem SJ, Hou X, Mohler ER, Parsons JK, Wenger NK, Zeldow B, Landis JR, Ellenberg SS. Effects of Testosterone Treatment in Older Men. New England Journal Of Medicine 2016, 374: 611-624. PMID: 26886521, PMCID: PMC5209754, DOI: 10.1056/nejmoa1506119.Peer-Reviewed Original ResearchConceptsMid-normal rangeMen 65 yearsSerum testosterone concentrationsYears of ageTestosterone treatmentTestosterone levelsTestosterone concentrationsMen 19Depressive symptomsOlder menChronic Illness Therapy-Fatigue ScalePsychosexual Daily QuestionnaireSerum testosterone levelsPercentage of menAdverse eventsErectile functionPrimary outcomePlacebo gelSexual functionStudy groupWalking distanceFunctional assessmentMen ageModerate benefitDaily questionnaires
2012
Sexual Functioning Among Endometrial Cancer Patients Treated With Adjuvant High-Dose-Rate Intra-Vaginal Radiation Therapy
Damast S, Alektiar KM, Goldfarb S, Eaton A, Patil S, Mosenkis J, Bennett A, Atkinson T, Jewell E, Leitao M, Barakat R, Carter J, Basch E. Sexual Functioning Among Endometrial Cancer Patients Treated With Adjuvant High-Dose-Rate Intra-Vaginal Radiation Therapy. International Journal Of Radiation Oncology • Biology • Physics 2012, 84: e187-e193. PMID: 22572074, PMCID: PMC5538259, DOI: 10.1016/j.ijrobp.2012.03.030.Peer-Reviewed Original ResearchMeSH KeywordsAdministration, IntravaginalAdolescentAdultAgedAged, 80 and overBrachytherapyCross-Sectional StudiesDehydrationDilatationEndometrial NeoplasmsFemaleHumansHysterectomyLaparotomyLibidoMiddle AgedOrgasmPainPersonal SatisfactionRadiotherapy DosageRadiotherapy, AdjuvantReference ValuesRegression AnalysisRisk FactorsSexual Dysfunction, PhysiologicalSurveys and QuestionnairesVaginal Creams, Foams, and JelliesVaginal DiseasesYoung AdultConceptsFemale Sexual Function IndexEndometrial cancer patientsSexual dysfunctionFSFI scoreSexual functioningCancer patientsEarly stage endometrial cancer patientsQuestionnaire completionRates of SDLubricant useLower FSFI scoresSexual Function IndexPoor sexual functioningRadiation oncology clinicPostmenopausal statusSimple hysterectomyPostmenopausal populationOncology clinicAdjuvant brachytherapyEC patientsRisk factorsFunction IndexRadiation therapyHigh doseMultivariate analysis
2009
FOREWORD
CARSON S, WIGGINS D. FOREWORD. Clinical Obstetrics & Gynecology 2009, 52: 654-655. PMID: 20393416, DOI: 10.1097/grf.0b013e3181bf4773.Peer-Reviewed Original Research
2006
Romantic Love and Sexual Desire in Close Relationships
Gonzaga G, Turner R, Keltner D, Campos B, Altemus M. Romantic Love and Sexual Desire in Close Relationships. Emotion 2006, 6: 163-179. PMID: 16768550, DOI: 10.1037/1528-3542.6.2.163.Peer-Reviewed Original Research
1995
Health-related quality of life in patients with advanced prostate cancer: A multinational perspective
Cleary P, Morrissey G, Oster G. Health-related quality of life in patients with advanced prostate cancer: A multinational perspective. Quality Of Life Research 1995, 4: 207-220. PMID: 7613531, DOI: 10.1007/bf02260860.Peer-Reviewed Original ResearchConceptsHealth-related qualityAdvanced prostate cancerProstate cancerSelf-administered patient questionnaireUntreated metastatic prostate cancerObjective tumor responseDomains of HRQOLMetastatic prostate cancerAntiandrogen therapyPatient questionnaireStudy entryTreatment failureStudy treatmentTumor responseClinical trialsPatientsCancerTrialsTreatmentQuestionnaireHRQoLAntiandrogensTherapyCastrationFocus of concern
1973
Effect of drug treatment for lymphoma on male reproductive capacity. Studies of men in remission after therapy.
Sherins R, DeVita V. Effect of drug treatment for lymphoma on male reproductive capacity. Studies of men in remission after therapy. Annals Of Internal Medicine 1973, 79: 216-20. PMID: 4580112, DOI: 10.7326/0003-4819-79-2-216.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAntineoplastic AgentsBiopsyBurkitt LymphomaCyclophosphamideGerm CellsHodgkin DiseaseHumansLibidoLymphoma, Large B-Cell, DiffuseLymphoma, Non-HodgkinMaleMethotrexateMiddle AgedNitrogen Mustard CompoundsPrednisoneProcarbazineRemission, SpontaneousSertoli CellsSpermatogenesisSpermatozoaTestisTime FactorsVincristine
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply